This week in MathOnco: 143
This week in MathOnco: 142
This week in MathOnco: 141
#MathOnco Issue 140: cancer adaptive therapy, persister cells, evolutionary trajectories, nonlinear reaction networks, cycling hypoxia
#MathOnco Issue 139: tumor vasculature, blood cancer heterogeneity, the tragedy of the commons in cancer, multidrug resistance
#MathOnco Issue 138: cancer's physical traits, clonal tracing, neoantigen heterogeneity, Moran Process, and more
#MathOnco Issue 137: cancer evolution, CAR-T cell therapy, adaptive cancer therapy, growth kinetics, antifragile therapy.
#MathOnco Issue 136: adaptive therapy, cancer metastasis, antiangiogenic treatment, boolean models, stochastic diff equations
#MathOnco Issue 135: bayesian radiotherapy, non-genetic resistance, stochastic PK/PD models, persistence, and drug-induced resistance.
#MathOnco Issue 134: cancer ecology, metastatic bottleneck, a review on model construction, checkpoint inhibitors, and more.
#MathOnco Issue 133: cancer evolution, Allee effects, invasion, immunology, chromosomal instability and more.
#MathOnco Issue 132: Goldilocks chemo, dose-dependent evolutionary games, fluid flow in tumors, polyploid nutrient deprivation.
#MathOnco Issue 131: evolutionary dynamics of neoantigens, colorectal cancer initiation, cancer/wound healing hallmarks, resistance & recurrence
#MathOnco Issue 130: tumor architecture, spatial structure, biomarkers, hypoxia/acidity, ecological principles applied to pesticides.
#MathOnco Issue 129: cancer evolution: subclonal reconstruction and chromosomal instability, genomic divergence, and more.
#MathOnco Issue 128: tumor spheroids, evolutionary control, glioblastoma, convergent evolution, and more.
#MathOnco Issue 127: collective invasion, drug-tolerable phenotypes, circulating tumor DNA, deterministic coexistence, and more.
#MathOnco Issue 126: eco-onccology, collective motion, reproducibility, multi-scale models, and more.
#MathOnco Issue 125: cancer eco-evo, superdrivers, dN/dS dynamics, neutral evolution, matrix games, go-or-grow, and more.
#MathOnco Issue 124: tumor-immune interactions, immuno-oncology models, evolution of resistance, AI, and personalized therapy.
#MathOnco Issue 123: simultaneous selection pressures, a phase-field prostate model, systems immunology, EGT control theory, genotype-phenotype
#MathOnco Issue 122: collateral sensitivity, clonal diversity, environmental manipulation, optimal therapy, and patient-specific dynamics.
#MathOnco Issue 121: Lotka-Volterra models, allee effects, cancer cachexia, cell plasticity, visualizing evolutionary games.
#MathOnco Issue 120: artificial intelligence clinical decision making, pharmacokinetic model software, glioblastoma invasion patterns, angiogenesis.
#MathOnco Issue 119: allee effects, optimal control theory, genetic composition, mutagenesis, agent-based simulations, and twitter trials.
#MathOnco Issue 118: optimal control, cancer invasion, growth laws, a heterogeneity unifying framework, and mechanism vs machine learning.
#MathOnco Issue 117: Lotka-Volterra, pest-management in cancer, NK cells, branching process tool, evolutionary bottlenecks in metastases.
#MathOnco Issue 116: collateral sensitivity, stromal reactivity, acquired resistance, cure vs containment, drug synergy, neutral syndrome
#MathOnco Issue 115: early detection, mechanistic models, Bayesian inference, tumor spheroids, web browser CA simulations, and more.
#MathOnco Issue 114: optimal treatment models, phenotypic diversity, tumor-parenchyma biomechanics, and evo-eco dynamics.
#MathOnco Issue 113: evolutionary steering, optimizing adaptive therapy, machine learning predictive treatments, Allee effects
#MathOnco Issue 112: cancer microenvironment, cell motility, micromet resistance, angiogenesis construction, and heteregeneity.
PSOC and CSBC Members - Survey for MathOnc20 meeting
Survey for MathOnc20 meeting
#MathOnco Issue 111: androgen deprivation therapy, invasive ecosystem cooperation, the DCIS microenvironment, and phenotypic switching.
#MathOnco Issue 110: Norton-Simon, mutator genes, biological networks, cancer cachexia, adaptive cancer therapy, carrying capacity
#MathOnco Issue 109: go-or-grow, ctDNA, hematopoiesis, dNdS, storage effect, and more..
#MathOnco Issue 108: colorectal tumor invasion, glioblastoma migration, entropy/heteregeneity, and metastatic potential/clonality.
#MathOnco Issue 107: chemo evolution, deleterious mutations, evolutionary therapy, a framework for hybrid modeling, and more
#MathOnco Issue 106: selecting for good science; immune cell behavior; clinical prediction; drug-induced resistance; reinforcement learning
#MathOnco Issue 105: glioblastoma models, drug synergistic effects, the cancer microbiome, organoid dynamics
#MathOnco Issue 104: population models; AI; multi-region sequencing; undergraduate MathOnco; twitter & academics
#MathOnco Issue 103: ctDNA, colorectal cancer initiation, selection dynamics, collateral sensitivity and more.
#MathOnco Issue 102: tumor-immune dynamics, branching processes, ecological scaffolding, clonal dynamics, epithelial-mesenchymal heterogeneity
#MathOnco Issue 101: clonal reconstruction, personalized prediction, cellular turnover, tumor containment, a Bayesian machine scientist
#MathOnco Issue 100: one hundredth issue!
#MathOnco Issue 99: phenotypic coexistence & switching, evolutionary trajectories & algorithms, CAR-T-cells & single cells, and more.
#MathOnco Issue 98: game theory, Darwinian evolution, subclonal reconstruction, glioblastoma's transient states, radiosensitivity in lung cancer
#MathOnco Issue 97: virtual clinical trials, immuno space-time dynamics, Muller's ratchet, objective functions, and more.
#MathOnco Issue 96: the mutability of cancer, predator-prey interactions, induced/spontaneous resistance, and optimal evolutionary control
